Evidence map›Paper›PMID 30008977›Full record

ArticleCanadian respiratory journal2018

Impact of Nasopharyngeal FilmArray Respiratory Panel Results on Antimicrobial Decisions in Hospitalized Patients.

Kenneth K Sakata, Natalya Azadeh, Anjuli Brighton, M'hamed Temkit, Christine L Klassen, Thomas E Grys, Holenarasipur R Vikram

Open access · goldAbstract read
In one paragraph

Article in Canadian respiratory journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Panels and Syndromic Testing in Clinical Microbiology.Clinics in laboratory medicine · 2020
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Kenneth K SakataDivision of Pulmonary Medicine, Mayo Clinic, Phoenix, AZ, USA.ORCID 0000-0003-3527-1612
Natalya AzadehDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-4952-8995
Anjuli BrightonDivision of Pulmonary Medicine, Mayo Clinic, Phoenix, AZ, USA.
M'hamed TemkitDivision of Health Sciences and Research, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Christine L KlassenDivision of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Thomas E GrysDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ, USA.
Holenarasipur R VikramDivision of Infectious Diseases, Mayo Clinic, Phoenix, AZ, USA.ORCID 0000-0002-6391-0349
Mayo Clinic · USMayo Clinic in Florida · USMayo Clinic Hospital · USMayo Clinic in Arizona · USWinnMed · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To determine whether results of the nasopharyngeal FilmArray respiratory panel (NP-FARP) influenced antibiotic decisions. Methods: We reviewed the medical records of nonintensive care unit (ICU) inpatients that had an NP-FARP performed at our institution between June 2013 and June 2014. The inpatient records were reviewed 48 hours after the NP-FARP for the following data: demographic information; NP-FARP, serum procalcitonin, and methicillin-resistant Results: A total of 545 patients were included. There were 143 (26%) patients with positive and 402 (74%) patients with negative NP-FARPs. Comparison of groups A, B, and C between those with a (+) and (-) NP-FARP were as follows: (+) A and (-) A, 28/143 (20%) and 84/402 (21%); (+) B and (-) B, 59/143 (41%) and 147/402 (37%); and (+) C and (-) C, 56/143 (39%) and 171/402 (43%), respectively. We found no statistically significant differences between groups (+) A versus (-) A, (+) B versus (-) B, and (+) C versus (-) C with respect to age, gender, MRSA NS result, procalcitonin result, or concurrent immunosuppression. Conclusion: In non-ICU inpatients, NP-FARP alone or in combination with procalcitonin or MRSA NS did not influence antibiotic decisions during the study period.

Indexed as

Clinical Decision-MakingAgedAnti-Bacterial AgentsBacterial InfectionsFemaleHospitalizationHumansImmunocompromised HostMaleMethicillin-Resistant Staphylococcus aureusMiddle AgedMolecular Diagnostic TechniquesNasopharynxProcalcitoninRespiratory Tract InfectionsRetrospective StudiesAnti-Bacterial AgentsProcalcitonin

Identifiers

PMID30008977
PMCPMC6020531
OpenAlexW2808308682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.